These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24663231)

  • 1. Redundant dopaminergic activity may enable compensatory axonal sprouting in Parkinson disease.
    Arkadir D; Bergman H; Fahn S
    Neurology; 2014 Mar; 82(12):1093-8. PubMed ID: 24663231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The degeneration of dopaminergic synapses in Parkinson's disease: A selective animal model.
    Morales I; Sanchez A; Rodriguez-Sabate C; Rodriguez M
    Behav Brain Res; 2015 Aug; 289():19-28. PubMed ID: 25907749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism.
    Liberatore GT; Finkelstein DI; Wong JY; Horne MK; Porritt MJ; Donnan GA; Howells DW
    Exp Neurol; 1999 Oct; 159(2):565-73. PubMed ID: 10506529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease.
    Anglade P; Tsuji S; Javoy-Agid F; Agid Y; Hirsch EC
    Ann Neurol; 1995 Feb; 37(2):265-72. PubMed ID: 7847868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial responses associated with dopaminergic striatal reinnervation following lesions of the rat substantia nigra.
    Stanic D; Tripanichkul W; Drago J; Finkelstein DI; Horne MK
    Brain Res; 2004 Oct; 1023(1):83-91. PubMed ID: 15364022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term changes in morphology, D2R expression and targets of regenerated dopaminergic terminals in the striatum after a partial lesion in the substantia nigra in the rat.
    Zeng X; Shen H; Zhao J; Cai Q; Wang C; Xu Q
    Brain Res; 2012 Apr; 1450():166-73. PubMed ID: 22424788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms compensating for dopamine loss in early Parkinson disease.
    Brotchie J; Fitzer-Attas C
    Neurology; 2009 Feb; 72(7 Suppl):S32-8. PubMed ID: 19221312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long distance directed axonal growth from human dopaminergic mesencephalic neuroblasts implanted along the nigrostriatal pathway in 6-hydroxydopamine lesioned adult rats.
    Wictorin K; Brundin P; Sauer H; Lindvall O; Björklund A
    J Comp Neurol; 1992 Sep; 323(4):475-94. PubMed ID: 1358925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restorative strategies for the dopaminergic nigrostriatal projection pathway.
    Nikkhah G
    Acta Neurochir Suppl; 2013; 117():79-85. PubMed ID: 23652661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrostriatal system plasticity in Parkinson's disease: effect of dopaminergic denervation and treatment.
    Hirsch EC
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S115-20; discussion S120-1. PubMed ID: 10762138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat.
    Walsh S; Finn DP; Dowd E
    Neuroscience; 2011 Feb; 175():251-61. PubMed ID: 21145947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.
    Melamed E; Hefti F; Wurtman RJ
    Isr J Med Sci; 1982 Jan; 18(1):159-63. PubMed ID: 6121770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neuronal sprouting and behavioral recovery in hemi-parkinsonian rats after implantation of amnion cells.
    Sheng JG; McShane LM; Plunkett RJ; Cummins AC; Oldfield EH; Kopin IJ; Palmatier MA
    Exp Neurol; 1993 Oct; 123(2):192-203. PubMed ID: 8405285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia.
    Lee J; Zhu WM; Stanic D; Finkelstein DI; Horne MH; Henderson J; Lawrence AJ; O'Connor L; Tomas D; Drago J; Horne MK
    Brain; 2008 Jun; 131(Pt 6):1574-87. PubMed ID: 18487277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat.
    Grealish S; Xie L; Kelly M; Dowd E
    Brain Res Bull; 2008 Nov; 77(5):312-9. PubMed ID: 18817852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age differences in morphological patterns of axonal sprouting and multiple innervation of neuromuscular junctions during muscle reinnervation following nerve crush injury.
    Zhou CJ; Kawabuchi M; Wang S; Liu WT; Hirata K
    Ann Anat; 2002 Sep; 184(5):461-72. PubMed ID: 12392326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.